Listen

Description


Show notes

Canadian Province Newfoundland and Labrador Adds Biosimilar Switching Policy



Yukon Becomes Tenth Canadian Jurisdiction to Add Biosimilars Switching Policy



Policy Recommendations for Improving Biosimilar Uptake in Belgium



Researchers Recommend Improvements for China’s Biosimilar Regulatory Policies



Dr Ivo Abraham Column: The 2022 WHO Biosimilar Guidelines—Loosening the Reins or Changing the Track? Part 2



The Increasing Access to Biosimilars Act of 2023 Introduced to Congress



Published Data Coupled With Real-world Evidence Show Safety of Biosimilar-to-Biosimilar Switching



Uptake Barriers Will Deter Future Competitors From Investing in Biosimilars, Julie Reed Warns